Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Splinter

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMJ Quality & Safety|March 6, 2012
Exploring the role of salient distracting clinical features in the emergence of diagnostic errors and the mechanisms through which reflection counteracts mistakesSílvia Mamede, Ted A W Splinter, Tamara van Gog, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancerM B Polee, J Verweij, P D Siersema, et al.
Psychological Research|April 1, 2010
Conscious thought beats deliberation without attention in diagnostic decision-making: at least when you are an expertSílvia Mamede, Henk G Schmidt, Remy M J P Rikers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam StudyClaire Siemes, Loes E Visser, Jan-Willem W Coebergh, et al.
British Journal of Cancer|March 5, 2002
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancerM B Polee, F A L M Eskens, M E L van der Burg, et al.
British Journal of Cancer|December 4, 2003
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapyM B Polee, W C J Hop, T C Kok, et al.
Journal of the National Cancer Institute|March 22, 2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerJan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMJ Quality & Safety|March 6, 2012
Exploring the role of salient distracting clinical features in the emergence of diagnostic errors and the mechanisms through which reflection counteracts mistakesSílvia Mamede, Ted A W Splinter, Tamara van Gog, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancerM B Polee, J Verweij, P D Siersema, et al.
Psychological Research|April 1, 2010
Conscious thought beats deliberation without attention in diagnostic decision-making: at least when you are an expertSílvia Mamede, Henk G Schmidt, Remy M J P Rikers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam StudyClaire Siemes, Loes E Visser, Jan-Willem W Coebergh, et al.
British Journal of Cancer|March 5, 2002
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancerM B Polee, F A L M Eskens, M E L van der Burg, et al.
British Journal of Cancer|December 4, 2003
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapyM B Polee, W C J Hop, T C Kok, et al.
Journal of the National Cancer Institute|March 22, 2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerJan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 2